From the Wires
Medivation Announces Participation at Upcoming Investor Conference
Feb. 6, 2013 04:10 PM
SAN FRANCISCO, CA -- (Marketwire) -- 02/06/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:
- Patrick Machado, chief business and financial officer, will present at the Leerink Swann Global Healthcare Conference on February 13 at 8:30am ET in New York, NY.
About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
About Marketwire .Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.